Etude Clinique de l'hypertension artérielle en
milieu hospitalier à Kinshasa. Mémoire
de spécialisation, Université de
Kinshasa, 1983.
43. FORRESTER T.
Historic and early life origins of hypertension in
Africans. J Nutr. 2004 Jan ; 134 (1) : 211
- 216.
44. J.P. VALAT ET B. FOUQUET.
Sommaire notes du cours de Rhumatologie.
Université de Tours 1999.
45. J.L. KURTZ.
Cours de Rhumatologie : Arthropathies
micro-cristallines (goutte, chondrocalcinose,
rhumatisme à hydroxyapatite). Faculté de
médecine - U.L.P F 67000 Strasbourg. 2002.
46. PAGE M.D.
Obesity in childhood and adolescence special problems in
diagnosis and treatment.
Post grad. Med J 1986, 79 : 233-249.
47. SCHOUL JM, ARMAND B , DUCIMETERE P, CHABDS D, BRAU J
ET AL . Comparaison of risk factors in vasospatic angina without significant
fixed coronary narrowing and no vasospatic angina. Am J Cardiol 1986; 57: 199-
202.
48. WORLD HEALTH ORGANIZATION / INTERNATIONAL SOCIETY OF
HYPERTENSION.
Pratique guidelines for primary carre Physicians .J
Hypertens 1999; 17: 151 - 183.
49. LONGO - MBENZA B.
Diabète sucré et maladies cardiovasculaires.
Cardiol Trop 1995; 21 ( 82) : 37- 44.
50. OMRAN A.R.
The epidemiologic transition, a key of the
epidemiology of population change. Milibank
Memorial Fund Q. 1971 ; 49 : 509-538.
51. PRESSART R.
L'analyse démographique, concepts
-méthodes,PUF, 1983, 294p.
52. SRINATH KR , YUSSUFF S.
Emerging epidemic of cardiovascular disease in developing
countries. Circulation.
1998 ;97 :596-601.
53 AVARES EF, VIEIRA- FILHO JP, ANDRIOLO A GIMENO SG, FRANCO
LJ. Metabolic profile and cardiovascular risk patterns of an Indian tribe
living in tthe amazon Region of Brazil. Hum. Biol . 2003 Feb ;
75(1) : 31- 46.
54. CORELLA D,SILLA J, ORDOVAS JM,SABATER A, RUIZ DE LA
FUENTE S, PORTOLES O, GONZALEZ JL,SAIZ C.
Association of blood uric acid with other cardiovascular risk
factors in the male working
population in valencia . Rev Clin Esp.1999 Dec ;199
(12) : 806-812.
55. RATTARASARN C, LEELAWATTANA R, SOONTHORNPUN S, SETASUBAN
W, THAMPRASIT A, LIM A, CHAYANUNNUKUL W, THAMKUMPEE N, DAENDUMRONGSUB T.
Regional abdominal fat distribution in learn and obese thai
type 2 diabetic women,
relationships with insulin sensitivity and cardiovascular
risk factors. Metabolism.
2003 ; Nov ; 52 (11) : 1444-1447.
56. CLAUSEN JO. BORSCH- JOHNSEN K, IBSEN H, PEDERSEN O.
Analysis of the relationship between fasting serum uric acid
and the insulin sensitivity index in a population-based sample of 380 young
healthy caucasians. Endocrinol. 1998 Jan ; 138(1) : 63-69.
57. TKAC I, BOMBA J, CVANIGOVA A.
Uric acid - a risk factor or artherosclerosis marker in
type 2 diabetes ? Vnitr lek.
1990 Aug ; 36 (8) : 763 - 768.
58. KA T, YAMAMOTO T, MORIWAKI Y, KAYA M, TSUJITA J,
TAKAHASHI S, TSUTSUMI Z, FUKUCHI M, HADA T.
Effect of exercise and beer on the plasma concentration and
urinary excretion of purine
bases. J Rheumatol. 2003 May ; 30 (5) : 1036 -
1042.
59. MIKKELSEN WM , DODGE HJ , VALDENBURG H.
The distribution of serum uric acid values in a
population unselected as to gout or
hyperuricemia : Tecumseh, Michigan, 1959 - 1960. Am
J Med 1965 ; 39 : 242 - 251.
60. COLLART F.
Insulino-resistance et hypertension artérielle.
Pathologie cardio-vasculaire, medisearch
1991 ;3(50) : 5-9.
61. GILLUM RF.
Blood Groups, Serum cholesterol, Serum uric acid, blood
pressure, and obesity in
adolescents. J Natl Med Assoc. 1991 Aug ; 83 (8) :
682-688.
62. AKHUND IA ; ALVI IA, ANSARI AK,
MUGHAL MA, AKHUND A. A.
A study of relationship of ABO blood groups with myocardial
infarction and angina pectoris. J Ayub Med Coll Abbottabad. 2001
oct-Dec ; 13 (4) : 25-26.
63. PLATT D ; MUHLBERG W ; KIEHL L ; SCHMITT R
.
A B O blood group System , age ,Sex , risk
factors and cardiac infarction. Arch Gerontol
Geriatr. 1985 oct ; 4 (3 ) : 241- 249 .
64. FALLER J, FOX IH.
Ethanol - induced hyperuricemia. N Engl J Med
1982 ;307 :1598-1602.
65. EASTMOND C J, GARTON M, ROBINS S, RIDDOCH S.
The effects of alcoholic beverages on urate metabolism in gout
suffers. Br J Rheumatol
1995 ;34 :756 - 759.
66. COWIE M R.
Alcohol and the heart. Br J Hosp Med
1997 ;57 :457-460.
67. BOFFETTA P, GARFINKEL L.
Alcohol drinking and mortality among men enroled in American
Cancer Society,
prospective study. Epidem. 1990 ; 1 : 342 - 348.
68. KLATSKY AL, ARMOSTRONG MA, FRIEDMAN G O.
Risk of cardiovascular mortality in alcohol drunkers, ex -
drinkers and non drinkers. Am J
cardiol 1990 ; 66 : 1237 - 1242.
69. BERTRAND ED. KACOU GM, MONKAM - M.
Maladie coronaire, sous développement et
développement comment le développement
économique favorise t-il les maladie coronaires
cardiol. Trop. 1984 ; 10( n° spécial ) :
51- 64.
70. DOBSON A J, GIBBER RW, LEEDER SR, O' CONNELL DL.
Mortality and risk factors in Australia. Am J Epidemiol
1985 ; 122 :283-290.
71. A MULTICENTER STUDY UK PROSPECTIVE DIABETES STUDY III.
Prevalence of hypertensive and hypotensive. Therapy in
patients with newly-diagnosed
diabetes hypertension. 1985 ;7 :118.
72. OPIT L J, OLIVIER GR, SALZBERG M.
Occupation and blood pressure. Med J Aust 1984 ; 140
(13) : 760-764.
73. SEEDAT YK, REDDY J.
The clinical pattern of hypertension in the South
African black population. A study of 1000
patients. A fr J Med Sci 1976 ; 5 : 1 -
7.
74. WELBORN , WEARNE K.
Coronary, heart disease incidence and cardiovascular
mortality in Busselton with
reference to glucose and insuline concentrations.
Diabetes care 1979 ; 2 : 154 - 160.
75. FREIDMAN M, THORESEN CE, GILL JY, ET AL.
Determination of type A behavior and its effect on cardiac
recurrences in post
myocardial infarctus patients : Summary results of the
recurrent caronary prevention
project. Am Heart J 1986 ; 112 : 653 - 664.
76. KEYS A, MENOTTI A ; ARAVORIS C ET AL.
The seven countries study 30 years of follow up from
Framingham study. JAMA 1987 ;
257 : 2176 - 2180.
77. SEEDAT YK.
Race, environnement, blood pressure : The South
African experience. J hyperters 1983 ;
1 : 7 - 12.
78. ROSE G, STAMLER J.
The intersalt study : Back-ground, methods and
main results. J hypertens 1980 ; 3 : 283
- 288.
79. LAWRENCE M TIERNEY, JR STEPHEN J MC PHEE, MAXINE A
PAPADAKIS.
Current Medical Diagnostics and Treatment.Tierney Mc Phee
Papadakis 2001.
Fortthieth edition Mc Graw - Hill.
80. ESCALLIER R.
La croissance des population urbaines en Afrique. ESP Pop Soc.
1998 ; 2 : 177-182.
81. BIELELI E , MOSWA J L, DITU M , KANDJINGU K , MULUMBA M.
Prevalence du diabète sucré au sein de la
population de Kinshasa . Congo Médical 2000,
II (15 ) : 1058 - 1061.
82. SHIRIKI K, KUMANYIKA.
Special issues regarding obesity in minority populations. Am
Inter Med 1933 ; 117 ( 7 ) :
650 - 654.
83. DELPEUCH F, MAINE B.
Obésité et développement des pays du sud
. Med Trop 1997 ;57 : 380 - 388.
84. DUCIMENTERE P, ESCHEVEGE E, PAPOZ L, ET AL.
Relationship of plasma insulin level to the incidence of
myocardial infarctus and
caronary heart disease mortality in a middle aged population.
Diabetologia 1980 ; 19 :
205 - 210.
85. MUYNK A. EPISTAT.
Institut de Médecine Tropicale Princes Léopold,
Anvers, 1996-1997.
86. POLIDORI MC, MECOCCI P ; STAHL W , SIES H.
Cigarette smoking cessation encreases plasma levels of several
antioxidant
micronutrients and improves resistance towards. Br J Nutr.
2003 Jul ; 90 (1) : 147-150.
87. FANG J, ALDERMAN MH.
Serum uric acid and cardiovascular mortality the NHANES I
epidemiologic follow - up
study, 1971- 1992. National Health and Nutrition Examination
survey.JAMA. 2000
May 10 ; 283 (18) : 2404 -2410.
88. PYORALA K, SAVOLAINE N E, KAUKOLAS S, HAAPAKOSKI J
Plasma insuline as coronary heart disease risK factor:
relationship to otherrisK factors and
predictive values during 91 year- flow up of the Helsinki
policeman population . Acta
Med Scand ( Suppl.) 1985; 710: 38 - 82.
89. KHOSLA T, LOWE CR.
Obésité and smoKing habit Social class.Br J
Prev Soc Med. 1972; 26: 249- 256.
90. BRUNCKERT E, EMMERICH J, DE LA HAYE F.ET AL.
Rôle des triglycérides dans les maladies
cardio-vasculaires. Arch. Mal Coeur 1992, 85 (
111) : 29 - 35.
91. GUIZE L, ILIOU MC.
Le traitement de facteurs de risque de
l'athérosclérose coronaire. Arch Mal Coeur
1992 ;85 :1687-1693.
92. CHARLES D, BARABE P ET TALBI D.
Infarctus du myocarde en Algérie . Cardiol . Trop.
1982; 8: 13 - 19.
93. SROLLE L, FISCHIER AK.
The social epidemiology of smoking behavior 1993 and 1970 .
the Midrown Manhatan
Study Soc sc Med, 1973 ; 358.
94. HOLME I, HELGELAND A, HJERMANN I, LUND - LARSEN PG, LEREN
P.
Coronary risK factors and socio- economic status, the Oslo
Study. Lancet . 1976; ii :
1396 -1398.
95. JACQUES - HENRRY WELL ET COLL.
Biochimie générale. 8è édition.
Masson 1997.
96. TOMITA M, MIZUMO S, YAMANAKA H, HOSODA Y, SAKUMA K,
MATUOKA Y, ODAKA M, YAMAGUCHI M, YOSIDA H, MORISAWA H, MURAYAMA T.
Does hyperuricemia affect mortality ? A prospective
cohort study of japanese male
workers. J Epidemiol. 2000 Nov ; 10 (6) :
403-409.
97. KORNITZER M, DRAMAIX M, KITTEL F, DE BACKER G.
Classe sociale et risque de cardiopathie schémique.
Rev. Prat. 1981; 35 (53 ) : 3805 -
3822.
98. LAGRUE G.
Peut -on endiguer l'épidémie tabagique ?
Rev. Prat, 1995 ; 320 :4-5.
99. MARMOT MG,ROSE G, SHIPLEY M AND HAMILTON PJS.
Employment grade and coronary heart disease in British Civil
Servants. J Epidem
Communly Health 1978 ; 32 :244-249.
100. P. BOULANGER, J POLONOVSKI, G. BISERTE, M. DAUTREVAUX.
Biochimie médicale. 3è édition revue
Masson 1997.
101. ZANETTI ET AL .
Smoking and attitudes to a non-smoking policy among
hospital staff. J Hum Hypertens(1998) 112, 57-62.
102. ZHU PB ET AL.
Cigarette Smoking among Junior high-School Students in
Beijing. China 1992, 21 : 584-861.
103. KOKKAVI A. COSTAS S.,
The epidemiology of licit and illicit substance use among
high-School students in
Greece. Am J Public Health. 1991 ;81 : 48 - 52.
104. ABOA E.A.C.
Facteurs de risque chez les coronariens noirs Africains :
Etude pilote cas témoins réalisée en cote d'Ivoire. MSC
thesis, IM T A, Antwerpen, 1996.
105. JEFFERSON JA, ESCUDERO E, HUTARDO ME, KELLY JP, SWENSON
ER, WENER MH, BURNIER M, MAILLARD M, SCHREINER GF, SCHOENE RB, HUTARDO A,
JOHNSON RJ.
Hyperuricemia, Hypertension, and proteinuria associated with
high - altitude polycythemia. Am J Kidney Dis 2002 Jun ; 39 (6) :
1135-1142.
106. MORIWAKI Y, YAMAMOTO T, TSUTSUMI Z, TAKAHASHI S, HADA
T.
Effects of angiotensin II infusion on renal excretion of
purine bases and oxypurinol.
Metabolism. 2002 Jul ; 51(7) : 893-895.
107. MESSERLI FH, FROHLICH ED, DRESLINSKI GR, SUAREZ DH,
ARISTIMUNO GG. Asymptomatic mild hyperuricemia : an indicator of
neprosclerosis in essential hypertension. Clin sci (lond). 1980 Dec ; 59
Suppl 6 : 409 S - 410 S.
108. MESSERLI FH, FROHLICH ED, DRESLINSKI GR, SUAREZ DH,
ARISTIMUNO GG. Serum uric acid in essential hypertension : an indicator of
renal vascular involvement. Ann Intern Med. 1980 Dec ; 93 (6)
: 817-821.
109. MARILDA MAZZALI, JOHN KANELLIS, LIN HAN, LILI FENG, YI -
YANG XIA, QIANG CHEN, DUK - HEE KANG, KATHERINE L. GORDON, SUSUMU WATANABE,
TAKAHIKO NAKAGAWA, HUI Y. LAN, AND RICHARD J. JOHNSON.
Hyperuricemia induces a primary renal arteriolopathy in rats
by a blood pressure- independent mechanism. Am J Physiol Renal Physiol
282 : F 991-F 997, 2002.
110. DANIEL I. FEIG ; RICHARD J. JOHNSON.
Hyperuricemia in childhood primary hypertension.
Hypertension. 2003 ; 42 : 247.
111. RICHARD J. JOHNSON , DUK -HEE KANG , DANIEL
FEIG , SALAH KIVLIGHN, JOHN KANELLIS ; SUSUMU WATANABE ;
KATHERINE R. TUTTLE ; BERNARDO RODRIGUEZ - ITURBE ; JAIME HERRERA -
ACOSTA ; MARILDA MAZZALI.
Is there a pathogenitic role for uric acid in hypertension
and cardiovascular and renal
disease. Hypertension . 2003 ; 41 : 1183.
112. ZALOKAR J, LELLOUCH J, CLAUDE JR ET AL.
Epidemiology of serum uric acid and gout Frenchmen. J chronic
Dis 1974 ; 27 : 59
- 75.
113. KINSEY D, WALTER R, SISE HS ET AL.
Incidence of hyperuricemia in 400 hypertension
patients.Circulation 1961 ; 42 :
972 - 973.
114. EDITORIAL.
Diurectics , hyperuricemia and Teinilic acid. Lancet
1980 ; 2 : 681 - 682.
115. BENGTSSON C.
Elevated serum uric levels during treatment with
antihypetensive drugs. Acta Med
Scand (suppl) 1979 ; 328 : 69 - 71.
116. NIKAS S, RIZOS E, MILIONIS H, BAIRAKTARI E, KALAITZIDIS
R, SIAMOPOULOS K, ELISAF M.
The effects of the addition of losartan on uric acid
metabolism in patients receiving
indapamide. J Renin Angiotension Aldosterone syst 2000
sep ; 1 (3) : 289 - 291.
117. KANNEL WB,MC GEE DL, GORDON TR.
A general cqrdiovascular risk profile : the Framingham
heart study. Am. J cardiol
1976 ; 38 :46-51.
118.TAKAHASHI S, MORIWAKI Y, YAMAMOTO T, TSUTSUMI Z, KA T,
FUKUCHI M. Effects of combination treatment using anti - hyperuricemia agents
with Fenofibrate and / or losartan on uric acid metabolism. Ann Rheum Dis.
2003 Jun ; 62 (6) : 572-575.
119. BERKOWITZ D.
Gout, hyyperlipidemia and diabetes interrelationships . J Am
med Assoc 1966 ; 114 :
117-120.
120. YANO K, THOADS G G, KANGAN A.
Epidemiology of Serum uric acid among 8000 Japonese -
American men in Hawai. J
Chronic Dis 1977; 30 : 171 - 184.
121.SIMMONDS H A ET AL.
| 
